CoQ10vsGotu Kola

CoQ10 (ubiquinone/ubiquinol) shuttles electrons between Complex I (NADH dehydrogenase) and Complex II (succinate dehydrogenase) and Complex III (cytochrome bc1 complex) of the mitochondrial electron transport chain. This is the fundamental process of oxidative phosphorylation—electrons flow through the chain to Complex IV, driving proton pumping and ATP synthesis via Complex V (ATP synthase). Without adequate CoQ10, the chain bottlenecks at the CoQ pool and energy production drops, particularly in high-metabolic tissues like neurons. As a lipid-soluble antioxidant, CoQ10 (in its reduced ubiquinol form) protects mitochondrial membranes from lipid peroxidation by terminating free radical chain reactions. It also regenerates vitamin E (tocopherol) from its radical form, amplifying antioxidant capacity. Brain CoQ10 levels decline with age.

Triterpene saponins (asiaticoside, madecassoside, asiatic acid, madecassic acid) are the primary bioactives. They increase BDNF expression in the hippocampus via CREB and ERK/MAPK pathways, promoting neuroplasticity, synaptogenesis, and memory formation. They enhance collagen type I synthesis through stimulation of fibroblasts and improve microcirculation via VEGF and angiopoietin modulation. Anxiolytic effects occur through positive allosteric modulation of GABA-A receptors (possibly at the benzodiazepine or neurosteroid site) and reduction of acoustic startle response (amygdala modulation). Gotu kola inhibits acetylcholinesterase (AChE), mildly increasing synaptic acetylcholine. Anti-inflammatory effects come from NF-kB inhibition (IkB stabilization) and TNF-alpha suppression. Asiatic acid may also activate PPAR-gamma.